newsfilter
← Latest News
Business Wire·

Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test

Cue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue RSV Molecular Test